高盛-爱博医疗(688050.SS):2025财年初步净利润因资产减值不及预期,目标价下调至人民币68元,维持中性评级-Eyebright(688050.SS):FY25prelim net profit missed due to impairments;TP down to Rmb68;Neutral-20260306【7页】

发表回复

后才能评论